Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

CTKB Q4 2020 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M

Gross Profit

$19M63.5% margin

Operating Income

$8M25.7% margin

Net Income

$6M18.3% margin

EPS (Diluted)

$0.05

QoQ Revenue Growth

+22.0%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$11M

Stock-Based Comp.

$271,000

Balance Sheet

Total Assets

$220M

Total Liabilities

$236M

Stockholders' Equity

-$16M

Cash & Equivalents

$165M

← FY 2020 All Quarters Q1 2021 →